Alana Fleet1, Stephen J Page2, Marilyn MacKay-Lyons3, Shaun G Boe4. 1. Laboratory for Brain Recovery and Function, School of Physiotherapy, Dalhousie University, Halifax, Nova Scotia. 2. School of Health and Rehabilitation Sciences, The Ohio State University Wexner Medical Center, Columbus, Ohio B.R.A.I.N. (Better Rehabilitation and Assessment for Improved Neuro-recovery) Laboratory, The Ohio State University Wexner Medical Center, Columbus, Ohio. 3. Laboratory for Brain Recovery and Function, School of Physiotherapy, Dalhousie University, Halifax, Nova Scotia Department of Medicine, Division of Physical Medicine and Rehabilitation, Capital Health, Halifax, Nova Scotia Department of Medicine, Division of Physical Medicine and Rehabilitation, Dalhousie University, Halifax, Nova Scotia. 4. Laboratory for Brain Recovery and Function, School of Physiotherapy, Dalhousie University, Halifax, Nova Scotia Department of Medicine, Division of Physical Medicine and Rehabilitation, Capital Health, Halifax, Nova Scotia Department of Medicine, Division of Physical Medicine and Rehabilitation, Dalhousie University, Halifax, Nova Scotia School of Health and Human Performance, Dalhousie University, Halifax, Nova Scotia Department of Psychology and Neuroscience, Dalhousie University, Halifax, Nova Scotia Canadian Partnership for Stroke Recovery, Sunnybrook Research Institute, Toronto, Ontario.
Abstract
BACKGROUND: Constraint-induced movement therapy (CIMT) is an effective treatment for upper extremity (UE) recovery post stroke. Difficulties implementing a traditional CIMT approach have led to development of protocols featuring varying practice schedules, including a 10-week, 3 times per week intervention, termed modified CIMT (mCIMT). To date, systematic reviews of CIMT have grouped the various protocols, precluding the ability to ascertain the level of evidence (LOE) of specific CIMT protocols. Knowing the LOE for various protocols and their relative effectiveness may facilitate decision making regarding which protocol to implement. OBJECTIVE: The aim of this study was to determine the LOE of mCIMT in promoting UE recovery post stroke. METHODS: A comprehensive literature search and subsequent analysis identified studies of a range of designs that investigated the mCIMT protocol. Two independent reviewers assigned an LOE to each of the identified studies, which were then examined collectively to determine the overall LOE for mCIMT. Study results were reviewed to assess the effectiveness of mCIMT for improving UE recovery. RESULTS: Of 473 studies identified, 15 utilized mCIMT. The lack of randomized controlled trials (RCT) resulted in assigning an intermediate LOE (C). Study results indicated that participants receiving mCIMT experienced clinically significant improvements in UE impairment and activity-level attributes. CONCLUSION: The mCIMT protocol is an effective intervention for UE recovery post stroke. Future research including large RCTs could potentially increase the LOE for mCIMT. Additional investigation into the effectiveness of mCIMT in acute and subacute stroke populations is warranted given the limited number of studies performed to date.
BACKGROUND: Constraint-induced movement therapy (CIMT) is an effective treatment for upper extremity (UE) recovery post stroke. Difficulties implementing a traditional CIMT approach have led to development of protocols featuring varying practice schedules, including a 10-week, 3 times per week intervention, termed modified CIMT (mCIMT). To date, systematic reviews of CIMT have grouped the various protocols, precluding the ability to ascertain the level of evidence (LOE) of specific CIMT protocols. Knowing the LOE for various protocols and their relative effectiveness may facilitate decision making regarding which protocol to implement. OBJECTIVE: The aim of this study was to determine the LOE of mCIMT in promoting UE recovery post stroke. METHODS: A comprehensive literature search and subsequent analysis identified studies of a range of designs that investigated the mCIMT protocol. Two independent reviewers assigned an LOE to each of the identified studies, which were then examined collectively to determine the overall LOE for mCIMT. Study results were reviewed to assess the effectiveness of mCIMT for improving UE recovery. RESULTS: Of 473 studies identified, 15 utilized mCIMT. The lack of randomized controlled trials (RCT) resulted in assigning an intermediate LOE (C). Study results indicated that participants receiving mCIMT experienced clinically significant improvements in UE impairment and activity-level attributes. CONCLUSION: The mCIMT protocol is an effective intervention for UE recovery post stroke. Future research including large RCTs could potentially increase the LOE for mCIMT. Additional investigation into the effectiveness of mCIMT in acute and subacute stroke populations is warranted given the limited number of studies performed to date.
Authors: Alexander B Remsik; Peter L E van Kan; Shawna Gloe; Klevest Gjini; Leroy Williams; Veena Nair; Kristin Caldera; Justin C Williams; Vivek Prabhakaran Journal: Front Hum Neurosci Date: 2022-07-06 Impact factor: 3.473
Authors: Alexander B Remsik; Leroy Williams; Klevest Gjini; Keith Dodd; Jaclyn Thoma; Tyler Jacobson; Matt Walczak; Matthew McMillan; Shruti Rajan; Brittany M Young; Zack Nigogosyan; Hemali Advani; Rosaleena Mohanty; Neelima Tellapragada; Janerra Allen; Mohsen Mazrooyisebdani; Leo M Walton; Peter L E van Kan; Theresa J Kang; Justin A Sattin; Veena A Nair; Dorothy Farrar Edwards; Justin C Williams; Vivek Prabhakaran Journal: Front Neurosci Date: 2019-03-06 Impact factor: 4.677
Authors: Fábio R O Galvão; Maria C A Silvestre; Camila L A Gomes; Nayara K F Pereira; Viviane T B Nóbrega; Wellington S Lima; Afonson L M Gondim; Enio W A Cacho; Roberta O Cacho Journal: Medicine (Baltimore) Date: 2021-02-26 Impact factor: 1.889
Authors: Na Jin Seo; Viswanathan Ramakrishnan; Michelle L Woodbury; Leonardo Bonilha; Christian Finetto; Christian Schranz; Gabrielle Scronce; Kristen Coupland; Jenna Blaschke; Adam Baker; Keith Howard; Caitlyn Meinzer; Craig A Velozo; Robert J Adams Journal: Trials Date: 2022-04-05 Impact factor: 2.279
Authors: Na Jin Seo; Derek G Kamper; Viswanathan Ramakrishnan; Jillian B Harvey; Christian Finetto; Christian Schranz; Gabrielle Scronce; Kristen Coupland; Keith Howard; Jenna Blaschke; Adam Baker; Caitlyn Meinzer; Craig A Velozo; Robert J Adams Journal: Trials Date: 2022-04-12 Impact factor: 2.279
Authors: Marios Spanakis; Ioanna Xylouri; Evridiki Patelarou; Athina Patelarou Journal: Int J Environ Res Public Health Date: 2022-07-28 Impact factor: 4.614